Dr. Maryam Asgari is a board-certified dermatologist, epidemiologist, and Mohs micrographic surgeon who specializes in the care of patients with skin cancer. Dr. Asgari's area of excellence is Investigation with a focus on epidemiology of skin diseases. Her research has focused on pharmacoepidemiology and skin cancer risk, interactions of immunity and skin cancer, high risk skin cancer, and patient-centered outcomes including patient satisfaction in skin cancer treatment. She is also known for her clinical expertise in procedural dermatology.
Dr. Asgari is also recognized as a clinical expert in Mohs surgery. She has served as an ad hoc reviewer for major journals including the American Journal of Epidemiology, Cancer Epidemiology, Biomarkers & Prevention, Dermatologic Surgery, JAMA Dermatology, Journal of the American Academy of Dermatology and Journal of Investigative Dermatology. She has also held national leadership positions in the Society of Investigative Dermatology and the American Academy of Dermatology. Within the American Academy of Dermatology, she was elected to serve as a member of the prestigious Melanoma and Skin Cancer Committee, which helps to establish guidelines for skin cancer care. She also served as an indication reviewer to help establish national guidelines for the Appropriate Use Criteria for Mohs surgery.